We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Impax for GMP Issues Following March Recall
FDA Warns Impax for GMP Issues Following March Recall
July 5, 2011
The FDA has warned Impax Laboratories for manufacturing violations related to finished pharmaceuticals after agency inspection findings prompted the company’s March recall of fenofibrate capsules.